Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

21.

Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.

N. Engl. J. Med.
Kantarjian HM, DeAngelo DJ, Stelljes M, Martinelli G, Liedtke M, Stock W, Gökbuget N, O'Brien S, Wang K, Wang T, Paccagnella ML, Sleight B, Vandendries E, Advani AS.
| Aug 25, 2016
22.

Universality of human microbial dynamics.

Nature.
Bashan A, Gibson TE, Friedman J, Carey VJ, Weiss ST, Hohmann EL, Liu YY.
| Jun 9, 2016
23.

Scaling identity connects human mobility and social interactions.

Proc. Natl. Acad. Sci. U.S.A.
Deville P, Song C, Eagle N, Blondel VD, Barabási AL, Wang D.
| Jun 28, 2016
24.

Responding to a Request for Physician-Assisted Death--Reply.

JAMA.
Quill TE, Back AL, Block SD.
| Jun 7, 2016
25.

Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases.

Nat. Med.
Ni J, Ramkissoon SH, Xie S, Goel S, Stover DG, Guo H, Luu V, Marco E, Ramkissoon LA, Kang YJ, Hayashi M, Nguyen QD, Ligon AH, Du R, Claus EB, Alexander BM, Yuan GC, Wang ZC, Iglehart JD, Krop IE, Roberts TM, Winer EP, Lin NU, Ligon KL, Zhao JJ.
| 06 06, 2016
26.

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.

N. Engl. J. Med.
Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, Gelmon K, Whelan T, Strasser-Weippl K, Rubin S, Sturtz K, Wolff AC, Winer E, Hudis C, Stopeck A, Beck JT, Kaur JS, Whelan K, Tu D, Parulekar WR.
| Jul 21, 2016
27.

Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits.

Cell.
Ulirsch JC, Nandakumar SK, Wang L, Giani FC, Zhang X, Rogov P, Melnikov A, McDonel P, Do R, Mikkelsen TS, Sankaran VG.
| Jun 2, 2016
28.

Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors.

Nature.
Jia Y, Yun CH, Park E, Ercan D, Manuia M, Juarez J, Xu C, Rhee K, Chen T, Zhang H, Palakurthi S, Jang J, Lelais G, DiDonato M, Bursulaya B, Michellys PY, Epple R, Marsilje TH, McNeill M, Lu W, Harris J, Bender S, Wong KK, Jänne PA, Eck MJ.
| Jun 2, 2016
30.

Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques.

Proc. Natl. Acad. Sci. U.S.A.
Li H, Wang S, Kong R, Ding W, Lee FH, Parker Z, Kim E, Learn GH, Hahn P, Policicchio B, Brocca-Cofano E, Deleage C, Hao X, Chuang GY, Gorman J, Gardner M, Lewis MG, Hatziioannou T, Santra S, Apetrei C, Pandrea I, Alam SM, Liao HX, Shen X, Tomaras GD, Farzan M, Chertova E, Keele BF, Estes JD, Lifson JD, Doms RW, Montefiori DC, Haynes BF, Sodroski JG, Kwong PD, Hahn BH, Shaw GM.
| Jun 14, 2016
31.

Landscape of tumor-infiltrating T cell repertoire of human cancers.

Nat. Genet.
Li B, Li T, Pignon JC, Wang B, Wang J, Shukla SA, Dou R, Chen Q, Hodi FS, Choueiri TK, Wu C, Hacohen N, Signoretti S, Liu JS, Liu XS.
| 05 30, 2016
32.

MEDICINE. Paying for future success in gene therapy.

Science.
Orkin SH, Reilly P.
| May 27, 2016
33.

CANCER. The cancer predisposition revolution.

Science.
Malkin D, Garber JE, Strong LC, Friend SH.
| May 27, 2016
34.

Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy.

Nature.
Li Z, Alyamani M, Li J, Rogacki K, Abazeed M, Upadhyay SK, Balk SP, Taplin ME, Auchus RJ, Sharifi N.
| May 26, 2016
35.

Acquired Tissue-Specific Promoter Bivalency Is a Basis for PRC2 Necessity in Adult Cells.

Cell.
Jadhav U, Nalapareddy K, Saxena M, O'Neill NK, Pinello L, Yuan GC, Orkin SH, Shivdasani RA.
| Jun 2, 2016
36.

Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity.

Proc. Natl. Acad. Sci. U.S.A.
Nakagawa H, Sido JM, Reyes EE, Kiers V, Cantor H, Kim HJ.
| May 31, 2016
37.

Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression.

Proc. Natl. Acad. Sci. U.S.A.
Komura K, Jeong SH, Hinohara K, Qu F, Wang X, Hiraki M, Azuma H, Lee GS, Kantoff PW, Sweeney CJ.
| May 31, 2016
38.

Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer.

Nat. Genet.
McPherson A, Roth A, Laks E, Masud T, Bashashati A, Zhang AW, Ha G, Biele J, Yap D, Wan A, Prentice LM, Khattra J, Smith MA, Nielsen CB, Mullaly SC, Kalloger S, Karnezis A, Shumansky K, Siu C, Rosner J, Chan HL, Ho J, Melnyk N, Senz J, Yang W, Moore R, Mungall AJ, Marra MA, Bouchard-Côté A, Gilks CB, Huntsman DG, McAlpine JN, Aparicio S, Shah SP.
| 05 16, 2016
39.

NLRC5/MHC class I transactivator is a target for immune evasion in cancer.

Proc. Natl. Acad. Sci. U.S.A.
Yoshihama S, Roszik J, Downs I, Meissner TB, Vijayan S, Chapuy B, Sidiq T, Shipp MA, Lizee GA, Kobayashi KS.
| May 24, 2016
40.

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.

Nat. Genet.
Campbell JD, Alexandrov A, Kim J, Wala J, Berger AH, Pedamallu CS, Shukla SA, Guo G, Brooks AN, Murray BA, Imielinski M, Hu X, Ling S, Akbani R, Rosenberg M, Cibulskis C, Ramachandran A, Collisson EA, Kwiatkowski DJ, Lawrence MS, Weinstein JN, Verhaak RG, Wu CJ, Hammerman PS, Cherniack AD, Getz G, Artyomov MN, Schreiber R, Govindan R, Meyerson M.
| 05 09, 2016